9th Digital Pathology and AI Congress - Europe

We presented a session titled "Imaging-based risk stratification solutions for prostate cancer care"

70th National Conference of IAPM & IAP-ID, APCON 2022

We presented a talk on imaging-based Artificial Intelligence applications for prostate cancer care.

29th PCF retreat in Carlsbad

Our collaborator Dr. Tamara L. Lotan, Johns Hopkins Medical presented some of the solutions we have been working on together: AI-based prediction of prostate cancer molecular subtype and metastasis using multi-modality data.

19th European Congress of Toxicologic Pathology

We conducted a workshop at the 19th European Congress of Toxicologic Pathology by Erio Barale-Thomas (Janssen R&D), Sabina Soldati (Pathology Experts GmBH) & Tijo Thomas (AIRA Matrix).

We discussed solutions for the automated stage-aware assessment of spermatogenesis in rodent testis, quantification of relevant toxicity endpoints in testis, as well as elucidate approaches for automated estrus staging and ovarian follicle counting in rodents.

2022 STP Annual Symposium

We presented a session titled "Application of Artificial Intelligence in Enhanced histopathology of Spleen" with Debra Tokarz, EPL.

We also presented four different applications of Deep Learning in Preclinical Toxicology around Rodent Liver, Kidney, Testes and Pancreas.

18th European Congress on Digital Pathology (ECDP)

We presented an oral presentation titled "Tumour region identification & TPS estimation of PDL-1 expression in NSCLC using deep learning" in the Machine Learning and AI-Clinical Application session.

We presented a poster titled "Deep learning-based application for sub-classification of Gleason pattern 4 in prostate carcinoma".

Transforming Digital Pathology & AI conference, Edinburgh

We presented our Prostate Cancer Decision Support Suite, designed to provide diagnostic, prognostic, and predictive assistance to Oncology teams.

USCAP 2022

We presented our prostate cancer decision support suite for the Prostate Cancer Care pathway.

Digital Pathology & AI, London, 2021

We talked about how Deep Learning networks trained on histopathological ground truth can increase the accuracy of non-invasive diagnostic technologies like mpMRI and provide a potential translational approach to better staging and therapeutic planning.


Pathology Visions 2021

Abstract title: A Deep Learning method for Tumour Region Identification and Tumour Proportion Score Estimation for PD L1 Expression in Non Small Cell Lung Carcinoma

We propose a computational technique using Deep Learning for detecting the cancer regions and calculating the Tumor Proportion Score (TPS) for PD L1 expression, in immunohistochemically stained sections from Non Small Cell Lung Carcinoma (NSCLC).

8th STP-I Annual Conference 2021

We demonstrated AIRADHI, an Image Management System for Preclinical Digital Pathology Workflows and Peer Reviews, at STP-I 2021.

Intelligent Health AI, 2021

Chaith Kondragunta, CEO of AIRA MATRIX, spoke at IHAI 2021 about the usage of deep learning applications in pathology.

Tech Talk


AIRA MATRIX presented two papers at the ARVO: IMAGING IN THE EYE CONFERENCE on May 13,2021.

The first presentation discussed a deep learning-based automated screening system capable of detecting and diagnosing diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), and few other pathologies in retinal images.

The second presentation introduced a deep learning tool for the early detection and grading of Diabetic Macular Edema (DME) using color fundus images, achieved by performing a LEsion Aware Prediction (LEAP) by segmenting hard exudates (HE).

Event Website


AIRA MATRIX hosted a session titled, “Demystifying Deep Learning for Pathologists” on June 25th, 2019 at the Society of Toxicologic Pathology (STP) 38th Annual Symposium.

4th Joint European Congress of the ESVP, ESTP and ECVP

AIRA MATRIX presented an informative session on optimizing preclinical pathology reporting using AI techniques. The session familiarized participants with deep learning (DL) modules that help speed up complex workflow processes in toxicologic pathology.


AIRA MATRIX announced the development of an Artificial Intelligence based image analysis solution for Rapid On Site Evaluation (“ROSE”) of EBUS-TBNA samples in collaboration with Dr. Suman Paul, Specialist Registrar in Respiratory Medicine, Warrington and Halton Hospitals NHS Foundation Trust.


By contuining to use this website, you consent to the use of cookies in accordance with our Cookie Policy

Got It